1. aState University of New York Upstate Medical University Syracuse, New York
2. bClinical Pharmacology and Quantitative Pharmacology, R&D, AstraZeneca, Gothenburg, Sweden
3. cClinical Development, Vaccines and Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom
4. dBiometrics, Vaccines and Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom
5. eSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit (Wits-VIDA), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
6. fClinical Development, Vaccines and Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland
7. gClinical Development, Vaccines and Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, Durham, North Carolina
8. hUniversity of California San Diego, San Diego, California
9. iPediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d’Hebron, and Vall d’Hebron Research Institute, Barcelona, Catalonia, Spain
10. jDepartment of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan